Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 82 results found. Search for [ NPPA ]

Results 20 to 40 of 82
www.businesstoday.in
New Delhi, June 13, 2017
The government has fixed GST rate of 12 per cent on most of the essential drugs as against the current tax incidence of around 9 per cent.


www.businesstoday.in
New Delhi, June 7, 2017
India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for price controls to reduce costs to patients.


www.businesstoday.in
Delhi, May 5, 2017
The stents that Abbott and Medtronic wanted to discontinue had a price tag of Rs 1,00,000-plus.


www.businesstoday.in
New Delhi/Mumbai, April 30, 2017
A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter.


www.businesstoday.in
Delhi, April 1, 2017
The tussle between two ministries is causing unwarranted distraction in the trouble-torn pharma space.


www.businesstoday.in
New Delhi, March 14, 2017
Since inception, the National Pharmaceutical Pricing Authority (NPPA) has issued 1,527 demand notices to companies for overcharging on sales of formulations at prices above the notified ceiling price.


www.businesstoday.in
March 2, 2017
What is the 'right price' for a medicine? This is a matter of constant debate and the response, as you would expect, pretty much depends on the economic background of the person answering the question.


www.businesstoday.in
February 28, 2017
These include drugs from some of the leading pharmaceutical companies like Sun Pharma, Cipla, Dr Reddy's, Alembic, Abbott Healthcare, GlaxoSmithKline among others.


www.businesstoday.in
February 14, 2017
It fixed a ceiling price of Rs. 7,250 apiece for bare metal stents, and allowed a maximum retail price of Rs. 29,600 for drug eluting stents of all varieties. The move will be more of a shocker to the hospitals than the companies as it is common knowledge that sticker prices on the stents are multiple times higher than the price at which companies sell these products to the hospitals.


www.businesstoday.in
New Delhi, January 20, 2017
The National Pharmaceutical Pricing Authority (NPPA) is seriously trying to regulate prices of stents to bring down angioplasty costs.


www.businesstoday.in
Delhi, November 12, 2016
Any change in the drug price control regime purely for ease of doing business can have serious ramifications.


www.businesstoday.in
September 6, 2016
Although there are norms and punishments for overcharging for medicines, but it is not a good idea for a consumer to just depend on the pharmaceutical companies or the pharmacies to get the correct price prescribed by the government as effective monitoring system is absent.


www.businesstoday.in
New Delhi, August 30, 2016
The central government will tweak the drug pricing norms to fix the prices of all 376 medicines that are included in the National List of Essential Medicines (NLEM) soon.


www.businesstoday.in
August 29, 2016
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.


www.businesstoday.in
New Delhi, August 19, 2016
\"NPPA has fixed/revised ceiling prices of 22 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016 and retail price of 13 formulations under DPCO, 2013,\" the National Pharmaceutical Pricing Authority (NPPA) said in a statement.


www.businesstoday.in
New Delhi, August 1, 2016
\"National Pharmaceutical Pricing Authority (NPPA) has fixed/revised ceiling prices of 24 scheduled formulations of schedule-I under Drugs (Price Control) Amendment Order, 2016,\" the drug pricing regulator said in a order on its website.


www.businesstoday.in
New Delhi, June 6, 2016
Prices of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 per cent.


www.businesstoday.in
New Delhi, April 26, 2016
The National Pharmaceutical Pricing Authority (NPPA) has issued notices to 263 firms that were found overcharging during 2015-16, Parliament was informed on Tuesday.


www.businesstoday.in
New Delhi, April 1, 2016
As many as 103 drug formulation packs, including those used for treating bacterial infections, diabetes, high blood pressure, tuberculosis, epilepsy, Hepatitis C and HIV/AIDS, have become cheaper.


www.businesstoday.in
December 29, 2015
While a total of 106 medicines have been added, 70 medicines have been deleted to finalise the new list.


PAGES 2 OF 5  12345